FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4376614892> ?p ?o ?g. }

• W4376614892 abstract "Abstract Context Explore the clinical characteristics and influencing factors of immune thyroid dysfunction (ITD) caused by immune checkpoint inhibitors (ICIs) in the treatment of malignant tumors. Methods This was a retrospective study of cancer patients treated with ICIs between January 2019 and December 2021 at the Second Affiliated Hospital of Nanchang University. According to the occurrence of thyroid dysfunction, patients were divided into an ITD group and non-ITD group. We describe the clinical characteristics, autoantibody levels, and their impact on prognosis of patients with ICI-related ITD. Result A total of 560 cases meeting the criteria were included, with a median follow-up time of 11.0 months. The incidence of ITD was 50.7%. Baseline TSH levels (OR, 1.935/mcIU/L; 95% CI, 1.613-2.321; P &lt; .001) and combination targeted therapy (OR, 2.101; 95% CI, 1.433-3.079; P &lt; .001) were most strongly associated with the occurrence of ITD. The median time to ITD in patients receiving medication with ICIs was 73 (34.5-149) days. Of the 87 patients initially diagnosed with hyperthyroid ITD, 46 (52.9%) progressed to hypothyroidism over the course of the disease. Baseline anti-thyroglobulin antibody abnormalities were strongly associated with the occurrence of ITD (OR, 67.393; 95% CI, 5.637-805.656; P = .001). Overall survival was significantly lower in patients who did not develop ITD than in those who did (hazard ratio, 0.523; 95% CI, 0.599-0.97; P &lt; .001). Conclusion The incidence of ICI-related ITD is high, and the course of the disease is rapidly changing, and thyroid function in patients treated with immunotherapy should be monitored to detect ITD and permit early intervention." @default.
• W4376614892 created "2023-05-17" @default.
• W4376614892 creator A5006598356 @default.
• W4376614892 creator A5027877230 @default.
• W4376614892 creator A5063224847 @default.
• W4376614892 date "2023-05-15" @default.
• W4376614892 modified "2023-09-26" @default.
• W4376614892 title "Clinical Characters and Influence Factors of Immune Checkpoint Inhibitor-related Thyroid Dysfunction" @default.
• W4376614892 cites W1974903851 @default.
• W4376614892 cites W2066671159 @default.
• W4376614892 cites W2094366129 @default.
• W4376614892 cites W2314357784 @default.
• W4376614892 cites W2561156916 @default.
• W4376614892 cites W2577007969 @default.
• W4376614892 cites W2613745448 @default.
• W4376614892 cites W2736166064 @default.
• W4376614892 cites W2750862728 @default.
• W4376614892 cites W2760410509 @default.
• W4376614892 cites W2766268302 @default.
• W4376614892 cites W2769814019 @default.
• W4376614892 cites W2782261845 @default.
• W4376614892 cites W2786816161 @default.
• W4376614892 cites W2804191059 @default.
• W4376614892 cites W2888278822 @default.
• W4376614892 cites W2891536507 @default.
• W4376614892 cites W2908586015 @default.
• W4376614892 cites W2912452927 @default.
• W4376614892 cites W2921353943 @default.
• W4376614892 cites W2940955228 @default.
• W4376614892 cites W2945590213 @default.
• W4376614892 cites W2947706938 @default.
• W4376614892 cites W2960671068 @default.
• W4376614892 cites W3003787744 @default.
• W4376614892 cites W3009244677 @default.
• W4376614892 cites W3011058953 @default.
• W4376614892 cites W3014190668 @default.
• W4376614892 cites W3019814596 @default.
• W4376614892 cites W3043703771 @default.
• W4376614892 cites W3103895771 @default.
• W4376614892 cites W3106005610 @default.
• W4376614892 cites W3120663487 @default.
• W4376614892 cites W3138556548 @default.
• W4376614892 cites W3153081776 @default.
• W4376614892 cites W3156514035 @default.
• W4376614892 cites W4206083771 @default.
• W4376614892 cites W4231116722 @default.
• W4376614892 doi "https://doi.org/10.1210/clinem/dgad260" @default.
• W4376614892 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37183427" @default.
• W4376614892 hasPublicationYear "2023" @default.
• W4376614892 type Work @default.
• W4376614892 citedByCount "0" @default.
• W4376614892 crossrefType "journal-article" @default.
• W4376614892 hasAuthorship W4376614892A5006598356 @default.
• W4376614892 hasAuthorship W4376614892A5027877230 @default.
• W4376614892 hasAuthorship W4376614892A5063224847 @default.
• W4376614892 hasBestOaLocation W43766148921 @default.
• W4376614892 hasConcept C120665830 @default.
• W4376614892 hasConcept C121332964 @default.
• W4376614892 hasConcept C126322002 @default.
• W4376614892 hasConcept C151730666 @default.
• W4376614892 hasConcept C159654299 @default.
• W4376614892 hasConcept C163764329 @default.
• W4376614892 hasConcept C167135981 @default.
• W4376614892 hasConcept C203014093 @default.
• W4376614892 hasConcept C207103383 @default.
• W4376614892 hasConcept C2778835679 @default.
• W4376614892 hasConcept C2779343474 @default.
• W4376614892 hasConcept C2779761222 @default.
• W4376614892 hasConcept C2994032529 @default.
• W4376614892 hasConcept C44249647 @default.
• W4376614892 hasConcept C526584372 @default.
• W4376614892 hasConcept C61511704 @default.
• W4376614892 hasConcept C71924100 @default.
• W4376614892 hasConcept C86803240 @default.
• W4376614892 hasConcept C90924648 @default.
• W4376614892 hasConceptScore W4376614892C120665830 @default.
• W4376614892 hasConceptScore W4376614892C121332964 @default.
• W4376614892 hasConceptScore W4376614892C126322002 @default.
• W4376614892 hasConceptScore W4376614892C151730666 @default.
• W4376614892 hasConceptScore W4376614892C159654299 @default.
• W4376614892 hasConceptScore W4376614892C163764329 @default.
• W4376614892 hasConceptScore W4376614892C167135981 @default.
• W4376614892 hasConceptScore W4376614892C203014093 @default.
• W4376614892 hasConceptScore W4376614892C207103383 @default.
• W4376614892 hasConceptScore W4376614892C2778835679 @default.
• W4376614892 hasConceptScore W4376614892C2779343474 @default.
• W4376614892 hasConceptScore W4376614892C2779761222 @default.
• W4376614892 hasConceptScore W4376614892C2994032529 @default.
• W4376614892 hasConceptScore W4376614892C44249647 @default.
• W4376614892 hasConceptScore W4376614892C526584372 @default.
• W4376614892 hasConceptScore W4376614892C61511704 @default.
• W4376614892 hasConceptScore W4376614892C71924100 @default.
• W4376614892 hasConceptScore W4376614892C86803240 @default.
• W4376614892 hasConceptScore W4376614892C90924648 @default.
• W4376614892 hasLocation W43766148921 @default.
• W4376614892 hasLocation W43766148922 @default.
• W4376614892 hasOpenAccess W4376614892 @default.
• W4376614892 hasPrimaryLocation W43766148921 @default.
• W4376614892 hasRelatedWork W161873529 @default.
• W4376614892 hasRelatedWork W1972113515 @default.

• next